Brainomix is a healthtech company that has pioneered the development of an AI platform to automate validated imaging biomarkers, initially focused on stroke assessment and expanding into other areas such as Interstitial Lung Disease (ILD) and solid tumor assessment.

Andrew Barker

Michalis Papadakis

Brainomix

MindMaze develops digital neurotherapeutics and assessments for motor and cognitive rehabilitation following neural injuries and degeneration. Their products include interactive therapies, monitoring tools, and platforms for tele-rehabilitation.

MindMaze

VMocion focuses on technology-related solutions, specifically in the fields of semiconductor, AI, and medical wearables. The company is involved in product development and innovation.

Metric
Company Name	Brainomix	MindMaze	VMocion
Symbol
MSH ID	COM:BRAINOMIX	COM:MINDMAZE	COM:VMOCION
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Technology
Industry	Healthcare & Health Services	Healthcare Technology	Technology and Innovation
Country		CH	US
Stage
Employee Count	11	101
Website	brainomix.com	mindmaze.com	vmocion.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		3.52K
Web Traffic Growth		0.11
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BRAI

COM:BRAINOMIX

Brainomix

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue